Giovanni is CEO of iDNA Ltd, a consulting firm for drug discovery and early preclinical development, helping start-up for funds raising through access to business investors, venture capital firms and pharmaceutical companies.
He is also Honorary Senior Lecturer at University College London (UCL) and Peer Reviewer Expert – European Commission.
He was Head of Biology at Intercept Pharmaceuticals (ICPT), a NY-based biotech company, focused on liver diseases from 2006 to 2014.
In 2014 was appointed Vice President of E3Bio, an Index Venture portfolio Company.
He received the MBA from HULT business school – London
